HVEM antibody

Catalog No. ABIN5589809

Product Details anti-HVEM Antibody

Target: HVEM (TNFRSF14) (Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HVEM antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Purpose: TNFRSF14 polyclonal antibody raised against recombinant human TNFRSF14.

Sequence: PPGDWGPPPW RSTPKTDVLR LVLYLTFLGA PCYAPALPSC KEDEYPVGSE CCPKCSPGYR VKEACGELTG TVCEPCPPGT YIAHLNGLSK CLQCQMCD

Cross-Reactivity: Human

Immunogen: Recombinant protein corresponding to amino acids of human TNFRSF14.

Isotype: IgG

Application Details

Application Notes: Immunofluorescence (1-4 μg/mL)
Immunohistochemistry (1:20-1:50)
Western Blot (1:100-1:250)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In PBS, pH 7.2 (40 % glycerol, 0.02 % sodium azide)

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Target Details for HVEM

Target: HVEM (TNFRSF14) (Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14))

Alternative Name: TNFRSF14 (TNFRSF14 Products)

Synonyms: ATAR antibody, CD270 antibody, HVEA antibody, HVEM antibody, LIGHTR antibody, TR2 antibody, Atar antibody, HveA antibody, Hvem antibody, Tnfrs14 antibody, TNF receptor superfamily member 14 antibody, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) antibody, Tnfrsf14 antibody, TNFRSF14 antibody

Target Type: Viral Protein

Background: Full Gene Name: tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
Synonyms: ATAR,HVEA,HVEM,LIGHTR,TR2

Gene ID: 8764

Pathways: Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints